CoChat

The radioenhancer NBTXR3: bridging physics and biology to improve radiotherapy outcomes and prime anti-tumor immunity

Open access
Bienassis, Célia, Vivar, Omar I., Hu, Yun, Da silva, Jordan, Darmon, Audrey, Marill, Julie, Anesary, Naeemunnisa Mohamed, Schmitt, Peter, Levy, Laurent, Welsh, James, Prezado, Yolanda, Megnin-Chanet, Frédérique, Paris, Sébastien · 2025 · Journal of Experimental & Clinical Cancer Research

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Radiotherapy remains a cornerstone in cancer treatment, used in over 50% of cases. It employs ionizing radiation, primarily X-rays, to target and destroy tumors through direct DNA damage and indirect effects via reactive oxygen species. Despite technological advancements improving precision of the delivered dose to the tumor, radiotherapy faces critical challenges, particularly damage to healthy tissues, which limits the maximum safe dose. Recent years have seen significant improvements in radiation delivery, including advanced imaging for real-time tumor tracking and combinations with immunotherapy. However, the need for innovative strategies to enhance radiotherapy’s therapeutic index remains essential. The radioenhancer NBTXR3 could represent a solution in addressing these limitations. This nanotechnology has been designed to amplify radiotherapy’s effects within tumors without increasing toxicity in non-injected adjacent healthy tissues. Beyond better cancer cell destruction and tumor control, radiotherapy-activated NBTXR3 nanoparticles can also stimulate systemic antitumor immune responses in preclinical models. This review aims to provide a comprehensive analysis of preclinical research on NBTXR3, focusing on its mechanism of action and role in initiating and enhancing antitumor immune responses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13046-025-03579-1

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Schematic representation of the composition of a nanoparticle of NBTXR3
Fig. 1 Schematic representation of the composition of a nanoparticle of NBTXR3CC BY · PubMed Central
Fig. 2 Principle of the physical mode of action of NBTXR3. Schematic representation of ROS generation between A a water molecule and B a NBTXR3 nanoparticle
Fig. 2 Principle of the physical mode of action of NBTXR3. Schematic representation of ROS generation between A a water molecule and B a NBTXR3 nanoparticleCC BY · PubMed Central
Fig. 3 Model presenting the biological responses induced by NBTXR3 alone or activated by radiotherapy
Fig. 3 Model presenting the biological responses induced by NBTXR3 alone or activated by radiotherapyCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Cited by

See all 9

Metadata

Authors
Bienassis, C., Vivar, O. I., Hu, Y., Da silva, J., Darmon, A., Marill, J., Anesary, N. M., Schmitt, P., Levy, L., Welsh, J., Prezado, Y., Megnin-Chanet, F., & Paris, S.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Nanobiotix (France) (FR)
  • The University of Texas MD Anderson Cancer Center (US)
Corresponding author
Paris, Sébastien
Venue
Journal of Experimental & Clinical Cancer Research
Published
2025-12-17
Volume
44
Issue
1
Pages
320-320
ISSN
  • 0392-9078 (ISSN-L)
  • 1756-9966
OpenAlex
W4417425991
Cited by
9
References
49
Citations by year
2026: 9
FWCI
1.56
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Experimental & Clinical Cancer Research (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
Keywords
NBTXR3, radiotherapy, radiosensitization, nanotechnology, antitumor immunity, DNA damage, reactive oxygen species, radiation toxicity, combination immunotherapy, therapeutic index
MeSH terms
Animals, Humans, Neoplasms, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The radioenhancer NBTXR3: bridging physics and biology to improve radiotherapy outcomes and prime anti-tumor immunity. https://app.cochat.ai/papers/10.1186/s13046-025-03579-1
The paper
Bienassis, C., Vivar, O. I., Hu, Y., Da silva, J., Darmon, A., Marill, J., Anesary, N. M., Schmitt, P., Levy, L., Welsh, J., Prezado, Y., Megnin-Chanet, F., & Paris, S. (2025). The radioenhancer NBTXR3: bridging physics and biology to improve radiotherapy outcomes and prime anti-tumor immunity. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-025-03579-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.